Skip to content
The Policy VaultThe Policy Vault

LupronMedical Mutual

Prophylaxis or Treatment of Uterine Bleeding in Patients with Hematologic Malignancy or Prior to Bone Marrow/Stem Cell Transplantation (BMT/SCT)

Initial criteria

  • Approve

Reauthorization criteria

  • Approve

Approval duration

1 year